Muhlis Akman
-
- Cancer, Hypoxia, and Metabolism 4
-
- Drug Transport and Resistance Mechanisms 3
-
- Metabolomics and Mass Spectrometry Studies 1
-
- Cancer, Stress, Anesthesia, and Immune Response 2
-
- Ion Channels and Receptors 2
-
- Immune cells in cancer 2
-
- Bioactive Compounds and Antitumor Agents 1
-
- MRI in cancer diagnosis 1
Muhlis Akman
14 papers receiving 445 citations
Peers
Comparison fields: 5 of 75
- Cancer Research 134
- Endocrine and Autonomic Systems 32
- Oncology 105
- Cell Biology 57
- Molecular Biology 202
Countries citing papers authored by Muhlis Akman
This map shows the geographic impact of Muhlis Akman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Muhlis Akman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Muhlis Akman more than expected).
Fields of papers citing papers by Muhlis Akman
This network shows the impact of papers produced by Muhlis Akman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Muhlis Akman. The network helps show where Muhlis Akman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Muhlis Akman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 9 | |
| 2 | 2024 | 9 | |
| 3 | 2023 | 10 | |
| 4 | 2023 | 17 | |
| 5 | 2022 | 26 | |
| 6 | 2022 | 24 | |
| 7 | 2021 | 8 | |
| 8 | 2021 | 117 | |
| 9 | 2020 | 38 | |
| 10 | 2020 | 96 | |
| 11 | 2020 | 29 | |
| 12 | 2018 | 15 | |
| 13 | Plasma thrombomodulin levels in lung cancer patients. | 1999 | 3 |
| 14 | 1993 | 52 |
About Muhlis Akman
Muhlis Akman is a scholar working on Cancer Research, Sensory Systems and Toxicology, having authored 14 papers that have together received 453 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Cancer, Stress, Anesthesia, and Immune Response (2 papers), Ion Channels and Receptors (2 papers), Immune cells in cancer (2 papers), Bioactive Compounds and Antitumor Agents (1 paper), MRI in cancer diagnosis (1 paper) and Metabolomics and Mass Spectrometry Studies (1 paper). The work is most often cited by research in Cancer Research (134 citations), Endocrine and Autonomic Systems (32 citations) and Oncology (105 citations). Muhlis Akman has collaborated with scholars based in Italy, Türkiye and Canada. Frequent co-authors include Chiara Riganti, Joanna Kopecka, Dimas Carolina Belisario, Massimo Donadelli, Enrico De Smaele, Iris C. Salaroglio, Nuray Erin, Martina Godel, Constance L. Chik and Angela Ho. Their work appears in journals such as Cells, Life Sciences, Journal of Experimental & Clinical Cancer Research, Clinical Cancer Research and Endocrinology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.